According to the latest reports Chloroquine phosphate has a curative effect on the novel coronavirus disease (COVID-19)
Lariago-DS (Chloroquine) is an antimalarial medicine which also exhibits amebicidal properties. It works by interacting with the DNA and blocking certain enzymes. This medicine is taken to prevent malaria infection and to treat somebody who has already become infected.
Malaria is caused when a mosquito that is infected with the plasmodium parasite bites a human and injects the parasite into the blood. Resulting from this, the parasites enter the liver, which facilitates there multiplication.
After this, they attack the blood cells, causing serious and life threatening symptoms. These can include severe fever, extreme muscular soreness and diarrhea. Extreme cases may affect the vital organs and brain. Use of this medicine targets the malaria parasite directly inside the red blood cells and causes their destruction. Although experts have stated that its main action is due to its effects on the DNA, it is also said to have plasmodicidal activity.
This medicine can also work for infections caused by other parasites, including a type of protozoa called entamoeba histolytica which is responsible for amebic dysentery. It has also been taken for amebic hepatitis. Medical research also shoed anti-inflammatory benefits, especially if used for autoimmune disorders like rheumatoid arthritis and lupus. When used over a six month period, it was shown to considerably improve symptoms. It is believed to work by affecting the immune system so as to alleviate inflammation.
Dosage and Administration
Lariago-DS (Chloroquine) tablets each contain 500mg of the active ingredient, and they are provided in a special blister strip which clearly marks when the medicine is to be taken. The dosage schedule can differ based on whether it is used for malaria prophylaxis (prevention) or an acute malaria attack. Your physician will tell you how and when to take it. Adults treating a malaria infection may be told to take 2 tablets (a total of 1000mg) for the first dose, and another 500mg (one tablet) 6 hours after the first dose. Another tablet should be taken 24 hours and 48 hours after the first tablet. This means that the patient will be told to take 2.5g (5 tablets) over a 3 day period. Close monitoring will also be needed for the entire duration of treatment. Amebiasis or other conditions may need a different dosing schedule.
Patients taking Lariago-DS (Chloroquine) for malaria or any other illness may experience side effects, such as:
- Lack of appetite
- Losing some hair
- Hair discoloration
- Dermatological photosensitivity
Promptly inform your caregiver of any side effects which you experience. Urgent treatment will be needed in the unlikely event that you experience bleeding from the gums, double vision, speech problems, dark colored urine, bruises or any other severe side effects that have not been referenced in this paragraph.
During treatment with Lariago-DS (Chloroquine) your physician may need to examine you and test the reflexes of your knees and other joints from time to time. It is important that you attend any medical appointments which are scheduled for you.
This medicine can make you dizzy, and it is important that you do not partake in any potentially dangerous activities if this occurs. It can also affect the skin and make you more susceptible to sunburn. Protect your skin if going outside.